Our website does not fully support your browser.

We've detected that you are using an older version of Internet Explorer. Your commerce experience may be limited. Please update your browser to Internet Explorer 11 or above.

We believe this site might serve you best:

United States

United States

Language: English

Promega's Cookie Policy

Our website uses functional cookies that do not collect any personal information or track your browsing activity. When you select your country, you agree that we can place these functional cookies on your device.

Factors to Consider for Designing and Optimizing Assays Applied to 3D Cultures

Topics covered include:

  • Designing detection reagents and appropriate controls to confirm lysis of all cells in 3D culture model systems
  • Measuring markers released into culture medium
  • The penetration of small molecule probes to interrogate biology within 3D structures
  • The potential to apply real-time multiplex detection methods with 3D models for high throughput screening

 

Summary

3D cell culture models are challenging when using assay chemistries and imaging methods originally designed for use with 2D cell culture models. The size of 3D structures, as well as the added complexity of scaffolds and matrix components used for culturing, often present barriers to directly measuring markers to assay biological function. In this webinar, we will present strategies and factors to consider when designing and validating assays applied to 3D cell culture models. We will also present case studies describing design of reagents and alternative approaches to overcome the limitations inherent with detecting markers from 3D culture models.

Speaker

terry-riss-125x125

Terry Riss, PhD
Global Strategic Marketing Manager, Cell Health

Dr. Terry Riss started the Cell Biology program at Promega Corporation in 1990 and held several R&D and Project Management positions since. Dr. Riss managed development of cell viability, cytotoxicity, apoptosis, and protease assay systems and also lead efforts to identify and promote multiplexing of cell-based assays to determine the mechanism of cell death.  Dr. Riss now serves as Global Strategic Marketing Manager, Cell Health involved in outreach educational training activities including validating assay systems applied to 3D cell culture models.

We love to talk science.

Sign up to receive monthly invitations to our webinars.

Sign Up